These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5855280)

  • 21. [Antitumor action of new 2,4-diethyleneimino-6-amino-sym.-triazina derivatives].
    Maliugina LL; Pol'kina RI; Kraĭz BO; Remizov AL
    Vopr Onkol; 1977; 23(12):70-5. PubMed ID: 602082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180.
    Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U
    Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of various antitumor agents on intracerebrally inoculated Ehrlich ascites carcinoma in mice (author's transl)].
    Zhou JX; He GH; Tao LX; Xu B
    Zhongguo Yao Li Xue Bao; 1981 Dec; 2(4):256-61. PubMed ID: 6462026
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antiblastic effect of various chemotherapeutic preparations on the cells of the Ehrlich ascites tumor].
    Papoian SA; Kumkumadzhian VA
    Vopr Onkol; 1966 Apr; 12(4):56-61. PubMed ID: 6001002
    [No Abstract]   [Full Text] [Related]  

  • 25. [On sensitivity to sarcolysine of Ehrlich's ascites tumors in mice "vaccinated" with treated tumor cells from animals previously treated with sarcolysine alone or with other antineoplastic drugs (thioguanine, actinomycin D)].
    Bonmassar E; Melan F; Testorelli C
    Arch Ital Patol Clin Tumori; 1968; 11(1):229-44. PubMed ID: 5745130
    [No Abstract]   [Full Text] [Related]  

  • 26. Antimitotic activity of the methylhydrazine derivative Natulan in the ehrlich ascites carcinoma; dose-effect relationship.
    Llombart A; Mínguez FP
    Oncology; 1969; 23(3):201-8. PubMed ID: 5785067
    [No Abstract]   [Full Text] [Related]  

  • 27. Antitumor effect of carboplatin combined with hyperthermia on Ehrlich-ascites tumor in vivo.
    Mizuuchi H; Yoshiga K; Sakurai K; Tsumura M; Takada K
    Anticancer Res; 1996; 16(1):381-7. PubMed ID: 8615640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor inhibition and hematological improvements by dopamine analog 3,4-dihydroxybenzylamine in mice bearing transplantable carcinoma.
    Lahiri T; Banerjee S; Dasgupta PS; Ray MR
    Neoplasma; 1990; 37(4):387-93. PubMed ID: 2234200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of some cancerostatics on the cytology and on the nucleic acid content in Ehrlich ascites cells in vivo.
    Veselá H; Jelínek V; Kejhová I
    Neoplasma; 1965; 12(4):365-72. PubMed ID: 5854407
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antineoplastic effects of various hydroxy acids on Ehrlich ascites carcinoma].
    Tomita M; Nagai K; Tsuchiya K; Sano A
    Hoppe Seylers Z Physiol Chem; 1965; 342(4):177-82. PubMed ID: 5884301
    [No Abstract]   [Full Text] [Related]  

  • 31. [Inhibition of the development of Ehrlich ascites carcinoma by drugs interfering with histamine].
    Bertolini A; Castelli M
    G Ital Chemioter; 1975; 22(1-2):51-4. PubMed ID: 14864
    [No Abstract]   [Full Text] [Related]  

  • 32. [Research on the antimitotic effect of treatment with combined pancreatic desoxyribonuclease and p-(N'-methylhydrazino-methyl)-N-iso-propyl-benzamide hydrochloride on the cells of Ehrlich's ascites tumor].
    Magliulo E; Petrocini S; Fossati GC; Gorini S
    Arch Sci Med (Torino); 1968 May; 125(5):179-84. PubMed ID: 5696482
    [No Abstract]   [Full Text] [Related]  

  • 33. Chloroaceto hydroxamic acid as antitumor agent against Ehrlich ascites carcinoma in mice.
    Sur P; Bag SP; Sur B; Khanam JA
    Neoplasma; 1997; 44(3):197-201. PubMed ID: 9372863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytocidal activity of plant auxin analogues against the Ehrlich ascites carcinoma.
    Schultz RD; Norman D
    Nature; 1965 Apr; 206(981):276-9 passim. PubMed ID: 5836320
    [No Abstract]   [Full Text] [Related]  

  • 35. Cell surface charges and invasion of drug resistant sublines of Ehrlich ascites tumor cells.
    Guoyan G; Li L; Meifang L; Longsheng H
    Chin Med J (Engl); 1979 Apr; 92(4):247-52. PubMed ID: 108056
    [No Abstract]   [Full Text] [Related]  

  • 36. Antitumor efficacy and amelioration of oxidative stress by Trichosanthes dioica root against Ehrlich ascites carcinoma in mice.
    Bhattacharya S; Prasanna A; Majumdar P; Kumar RB; Haldar PK
    Pharm Biol; 2011 Sep; 49(9):927-35. PubMed ID: 21819262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor organometallics. II. Inhibitory effects of two diphenyl-antimony (III) dithiophosphorus derivatives on in vitro and in vivo Ehrlich ascites tumor.
    Socaciu C; Bara A; Silvestru C; Haiduc I
    In Vivo; 1991; 5(4):425-8. PubMed ID: 1667268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Primary suspended cultures of tumor cells from transplantable ascites tumors as a model for the study of antitumor compounds].
    Ivanitskii LP; Makukho LV
    Vopr Onkol; 1973 May; 19(5):67-71. PubMed ID: 4714738
    [No Abstract]   [Full Text] [Related]  

  • 39. Antitumor properties of boron complexes with hydroxy biguanide and salicyl hydroxamic acid against Ehrlich ascites carcinoma.
    Ghosh P; Bag SP; Sur B; Sur P
    Neoplasma; 1998; 45(2):68-72. PubMed ID: 9687884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pt-ATP as an antineoplastic agent in an experimental mice model system.
    Pal S; Mukherjea K; Bhattacharya R; Maity P
    J Exp Clin Cancer Res; 1997 Sep; 16(3):255-60. PubMed ID: 9387898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.